Sfoglia per Autore ELENA, CHIARA
JAK2 (V617F) as an acquired somatic mutation and a secondary genetic event associated with disease progression in familial myeloproliferative disorders
2006-01-01 Rumi, Elisa; Passamonti, F; Pietra, D; DELLA PORTA, MATTEO GIOVANNI; Arcaini, Luca; Boggi, S; Elena, Chiara; Boveri, E; Pascutto, C; Lazzarino, M; Cazzola, Mario
HLA typing and VH gene rearrangement analysis in a family with hairy cell leukaemia
2007-01-01 Rumi, Elisa; Passamonti, F; Zibellini, S; Martinetti, M; Arcaini, Luca; Elena, Chiara; Cazzola, Mario; Lazzarino, M.
Familial chronic myeloproliferative disorders: clinical phenotype and evidence of disease anticipation
2007-01-01 Rumi, Elisa; Passamonti, Francesco; DELLA PORTA, MATTEO GIOVANNI; Elena, Chiara; Arcaini, Luca; Vanelli, L; DEL CURTO, Cecilia; Pietra, Daniela; Boveri, Emanuela; Pascutto, Cristiana; Cazzola, Mario; Lazzarino, Mario
Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V>F) mutation
2007-01-01 Passamonti, F; Randi, Ml; Rumi, Elisa; Pungolino, E; Elena, Chiara; Pietra, D; Scapin, M; Arcaini, Luca; Tezza, F; Moratti, Remigio; Pascutto, C; Fabris, F; Morra, E; Cazzola, Mario; Lazzarino, M.
A dynamic prognostic model to predict survival in post-polycythemia vera myelofibrosis
2008-01-01 Passamonti, Francesco; Rumi, Elisa; Caramella, M; Elena, Chiara; Arcaini, Luca; Boveri, E; Del Curto, C; Pietra, D; Vanelli, L; Bernasconi, Paolo; Pascutto, C; Cazzola, Mario; Morra, E; Lazzarino, Mario
Bone marrow microvessel density in chronic myeloproliferative disorders: a study of 115 patients with clinicopathological and molecular correlations
2008-01-01 Boveri, E; Passamonti, F; Rumi, Elisa; Pietra, D; Elena, Chiara; Arcaini, Luca; Pascutto, C; Castello, Alessandro; Cazzola, Mario; Magrini, Umberto; Lazzarino, Mario
Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients
2008-01-01 Passamonti, F; Rumi, Elisa; Arcaini, Luca; Boveri, E; Elena, Chiara; Pietra, C; Boggi, S; Astori, C; Bernasconi, Paolo; Varettoni, M; Brusamolino, E; Pascutto, C; Lazzarino, M.
Central nervous system relapse occurs in about 5% of cases of acute promyelocytic leukaemia
2008-01-01 Castagnola, Carlo; Elena, Chiara; Merli, Michele
Blood p50 evaluation enhances diagnostic definition of isolated erythrocytosis.
2009-01-01 Rumi, Elisa; Passamonti, Francesco; Pagano, L; Ammirabile, M; Arcaini, Luca; Elena, Chiara; Flagiello, A; Tedesco, R; Vercellati, C; Marcello, Ap; Pietra, D; Moratti, Remigio; Cazzola, Mario; Lazzarino, Mario
Blast phase of essential thrombocythemia: A single center study.
2009-01-01 Passamonti, Francesco; Rumi, Elisa; Arcaini, Luca; Elena, Chiara; Castagnola, C; Zappasodi, P; Bernasconi, Paolo; Pietra, D; Pascutto, C; Cazzola, Mario; Lazzarino, Mario
Molecular remission after allo-SCT in a patient with post-essential thrombocythemia myelofibrosis carrying the MPL (W515A) mutation.
2010-01-01 Rumi, Elisa; Passamonti, Francesco; Arcaini, Luca; Bernasconi, Paolo; Elena, Chiara; Pietra, D; Brisci, A; Arbustini, Eloisa; Cazzola, Mario; Lazzarino, Mario
Mutational status of myeloproliferative neoplasms.
2010-01-01 Rumi, Elisa; Elena, Chiara; Passamonti, Francesco
A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications.
2010-01-01 Passamonti, Francesco; Rumi, Elisa; Pietra, D; Elena, Chiara; Boveri, E; Arcaini, Luca; Roncoroni, E; Astori, C; Merli, M; Boggi, S; Pascutto, C; Lazzarino, Mario; Cazzola, Mario
Incidence of leukaemia in patients with primary myelofibrosis and RBC-transfusion-dependence.
2010-01-01 Passamonti, Francesco; Rumi, Elisa; Elena, Chiara; Arcaini, Luca; Merli, M; Pascutto, C; Cazzola, Mario; Lazzarino, Mario
Validation of cytogenetic-based risk stratification in primary myelofibrosis.
2010-01-01 Rumi, Elisa; Passamonti, Francesco; Bernasconi, Paolo; Arcaini, Luca; Pietra, D; Elena, Chiara; Boveri, E; Pascutto, C; Cazzola, Mario; Lazzarino, Mario
Identification of genomic aberrations associated with disease transformation by means of high-resolution SNP array analysis in patients with myeloproliferative neoplasm
2011-01-01 Rumi, Elisa; Harutyunyan, A; Elena, Chiara; Pietra, D; Klampfl, T; Bagienski, K; Berg, T; Casetti, I; Pascutto, C; Passamonti, Francesco; Kralovics, R; Cazzola, Mario
Flow-FISH evaluation of telomere length in Philadelphia-negative myeloproliferative neoplasms.
2011-01-01 Elena, Chiara; Rumi, Elisa; Portolan, M; Della Porta, Mg; Pascutto, C; Passamonti, F.
Increased risk of lymphoid neoplasm in patients with myeloproliferative neoplasm: a study of 1,915 patients.
2011-01-01 Rumi, Elisa; Passamonti, F; Elena, Chiara; Pietra, D; Arcaini, Luca; Astori, C; Zibellini, S; Boveri, E; Pascutto, C; Lazzarino, Mario
Red blood cell transfusion-dependency implies a poor survival in primary myelofibrosis irrespective of IPSS and DIPSS.
2011-01-01 Elena, Chiara; Passamonti, F; Rumi, Elisa; Malcovati, Luca; Arcaini, Luca; Boveri, E; Merli, M; Pietra, D; Pascutto, C; Lazzarino, Mario
Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations.
2011-01-01 Passamonti, F; Elena, Chiara; Schnittger, S; Skoda, Rc; Green, Ar; Girodon, F; Kiladjian, Jj; Mcmullin, Mf; Ruggeri, M; Besses, C; Vannucchi, Am; Lippert, E; Gisslinger, H; Rumi, Elisa; Lehmann, T; Ortmann, Ca; Pietra, D; Pascutto, C; Haferlach, T; Cazzola, Mario
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
JAK2 (V617F) as an acquired somatic mutation and a secondary genetic event associated with disease progression in familial myeloproliferative disorders | 1-gen-2006 | Rumi, Elisa; Passamonti, F; Pietra, D; DELLA PORTA, MATTEO GIOVANNI; Arcaini, Luca; Boggi, S; Elena, Chiara; Boveri, E; Pascutto, C; Lazzarino, M; Cazzola, Mario | |
HLA typing and VH gene rearrangement analysis in a family with hairy cell leukaemia | 1-gen-2007 | Rumi, Elisa; Passamonti, F; Zibellini, S; Martinetti, M; Arcaini, Luca; Elena, Chiara; Cazzola, Mario; Lazzarino, M. | |
Familial chronic myeloproliferative disorders: clinical phenotype and evidence of disease anticipation | 1-gen-2007 | Rumi, Elisa; Passamonti, Francesco; DELLA PORTA, MATTEO GIOVANNI; Elena, Chiara; Arcaini, Luca; Vanelli, L; DEL CURTO, Cecilia; Pietra, Daniela; Boveri, Emanuela; Pascutto, Cristiana; Cazzola, Mario; Lazzarino, Mario | |
Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V>F) mutation | 1-gen-2007 | Passamonti, F; Randi, Ml; Rumi, Elisa; Pungolino, E; Elena, Chiara; Pietra, D; Scapin, M; Arcaini, Luca; Tezza, F; Moratti, Remigio; Pascutto, C; Fabris, F; Morra, E; Cazzola, Mario; Lazzarino, M. | |
A dynamic prognostic model to predict survival in post-polycythemia vera myelofibrosis | 1-gen-2008 | Passamonti, Francesco; Rumi, Elisa; Caramella, M; Elena, Chiara; Arcaini, Luca; Boveri, E; Del Curto, C; Pietra, D; Vanelli, L; Bernasconi, Paolo; Pascutto, C; Cazzola, Mario; Morra, E; Lazzarino, Mario | |
Bone marrow microvessel density in chronic myeloproliferative disorders: a study of 115 patients with clinicopathological and molecular correlations | 1-gen-2008 | Boveri, E; Passamonti, F; Rumi, Elisa; Pietra, D; Elena, Chiara; Arcaini, Luca; Pascutto, C; Castello, Alessandro; Cazzola, Mario; Magrini, Umberto; Lazzarino, Mario | |
Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients | 1-gen-2008 | Passamonti, F; Rumi, Elisa; Arcaini, Luca; Boveri, E; Elena, Chiara; Pietra, C; Boggi, S; Astori, C; Bernasconi, Paolo; Varettoni, M; Brusamolino, E; Pascutto, C; Lazzarino, M. | |
Central nervous system relapse occurs in about 5% of cases of acute promyelocytic leukaemia | 1-gen-2008 | Castagnola, Carlo; Elena, Chiara; Merli, Michele | |
Blood p50 evaluation enhances diagnostic definition of isolated erythrocytosis. | 1-gen-2009 | Rumi, Elisa; Passamonti, Francesco; Pagano, L; Ammirabile, M; Arcaini, Luca; Elena, Chiara; Flagiello, A; Tedesco, R; Vercellati, C; Marcello, Ap; Pietra, D; Moratti, Remigio; Cazzola, Mario; Lazzarino, Mario | |
Blast phase of essential thrombocythemia: A single center study. | 1-gen-2009 | Passamonti, Francesco; Rumi, Elisa; Arcaini, Luca; Elena, Chiara; Castagnola, C; Zappasodi, P; Bernasconi, Paolo; Pietra, D; Pascutto, C; Cazzola, Mario; Lazzarino, Mario | |
Molecular remission after allo-SCT in a patient with post-essential thrombocythemia myelofibrosis carrying the MPL (W515A) mutation. | 1-gen-2010 | Rumi, Elisa; Passamonti, Francesco; Arcaini, Luca; Bernasconi, Paolo; Elena, Chiara; Pietra, D; Brisci, A; Arbustini, Eloisa; Cazzola, Mario; Lazzarino, Mario | |
Mutational status of myeloproliferative neoplasms. | 1-gen-2010 | Rumi, Elisa; Elena, Chiara; Passamonti, Francesco | |
A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications. | 1-gen-2010 | Passamonti, Francesco; Rumi, Elisa; Pietra, D; Elena, Chiara; Boveri, E; Arcaini, Luca; Roncoroni, E; Astori, C; Merli, M; Boggi, S; Pascutto, C; Lazzarino, Mario; Cazzola, Mario | |
Incidence of leukaemia in patients with primary myelofibrosis and RBC-transfusion-dependence. | 1-gen-2010 | Passamonti, Francesco; Rumi, Elisa; Elena, Chiara; Arcaini, Luca; Merli, M; Pascutto, C; Cazzola, Mario; Lazzarino, Mario | |
Validation of cytogenetic-based risk stratification in primary myelofibrosis. | 1-gen-2010 | Rumi, Elisa; Passamonti, Francesco; Bernasconi, Paolo; Arcaini, Luca; Pietra, D; Elena, Chiara; Boveri, E; Pascutto, C; Cazzola, Mario; Lazzarino, Mario | |
Identification of genomic aberrations associated with disease transformation by means of high-resolution SNP array analysis in patients with myeloproliferative neoplasm | 1-gen-2011 | Rumi, Elisa; Harutyunyan, A; Elena, Chiara; Pietra, D; Klampfl, T; Bagienski, K; Berg, T; Casetti, I; Pascutto, C; Passamonti, Francesco; Kralovics, R; Cazzola, Mario | |
Flow-FISH evaluation of telomere length in Philadelphia-negative myeloproliferative neoplasms. | 1-gen-2011 | Elena, Chiara; Rumi, Elisa; Portolan, M; Della Porta, Mg; Pascutto, C; Passamonti, F. | |
Increased risk of lymphoid neoplasm in patients with myeloproliferative neoplasm: a study of 1,915 patients. | 1-gen-2011 | Rumi, Elisa; Passamonti, F; Elena, Chiara; Pietra, D; Arcaini, Luca; Astori, C; Zibellini, S; Boveri, E; Pascutto, C; Lazzarino, Mario | |
Red blood cell transfusion-dependency implies a poor survival in primary myelofibrosis irrespective of IPSS and DIPSS. | 1-gen-2011 | Elena, Chiara; Passamonti, F; Rumi, Elisa; Malcovati, Luca; Arcaini, Luca; Boveri, E; Merli, M; Pietra, D; Pascutto, C; Lazzarino, Mario | |
Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations. | 1-gen-2011 | Passamonti, F; Elena, Chiara; Schnittger, S; Skoda, Rc; Green, Ar; Girodon, F; Kiladjian, Jj; Mcmullin, Mf; Ruggeri, M; Besses, C; Vannucchi, Am; Lippert, E; Gisslinger, H; Rumi, Elisa; Lehmann, T; Ortmann, Ca; Pietra, D; Pascutto, C; Haferlach, T; Cazzola, Mario |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile